Soluble ST2 and N-terminal pro-Brain Natriuretic Peptide Combination
-
- Chida Ayako
- Departments of Pediatrics, National Defense Medical College Department of Pediatric Cardiology, Tokyo Women’s Medical University
-
- Sato Hiroki
- Preventive Medicine and Public Health, National Defense Medical College
-
- Shintani Masaki
- Department of Pediatric Cardiology, Tokyo Women’s Medical University
-
- Nakayama Tomotaka
- Department of Pediatrics, Toho University Medical Center, Omori Hospital
-
- Kawamura Yoichi
- Departments of Pediatrics, National Defense Medical College
-
- Furutani Yoshiyuki
- Department of Pediatric Cardiology, Tokyo Women’s Medical University
-
- Inai Kei
- Department of Pediatric Cardiology, Tokyo Women’s Medical University
-
- Saji Tsutomu
- Department of Pediatrics, Toho University Medical Center, Omori Hospital
-
- Matsuoka Rumiko
- International Research and Educational Institute for Integrated Medical Sciences (IREIIMS), Tokyo Women’s Medical University International Center for Molecular, Cellular and Immunological Research (IMCIR), Tokyo Women’s Medical University Department of Pediatrics, Faculty of Medicine, Toho University
-
- Nonoyama Shigeaki
- Departments of Pediatrics, National Defense Medical College
-
- Nakanishi Toshio
- Department of Pediatric Cardiology, Tokyo Women’s Medical University
Bibliographic Information
- Other Title
-
- Soluble ST2 and N-terminal pro-Brain Natriuretic Peptide Combination : Useful Biomarker for Predicting Outcome of Childhood Pulmonary Arterial Hypertension
- – Useful Biomarker for Predicting Outcome of Childhood Pulmonary Arterial Hypertension –
Search this article
Abstract
Background: Some potential biomarkers have been reported recently in patients with pulmonary arterial hypertension (PAH), but the most clinically useful among these potential biomarkers, especially in childhood PAH, has not been identified. Therefore, this study investigated which biomarker is useful in assessing severity of and patient prognosis in childhood idiopathic PAH (IPAH)/heritable PAH (HPAH). Methods and Results: Fifty-nine patients who were younger than 16 years at onset of IPAH/HPAH were selected. The following 10 biomarker candidates were quantified: high-sensitivity troponin T, human heart fatty acid-binding protein, N-terminal pro-brain natriuretic peptide (NT-proBNP), pentraxin-3, soluble ST2 (sST2), angiopoietin-2 (Ang-2), matrix metalloproteinase 2, tenascin C, endostatin (ES), and thymidine kinase. Functional characteristics and clinical outcomes were analyzed retrospectively. NT-proBNP, sST2, Ang-2, and ES correlated well with New York Heart Association class. On area under the receiver operating characteristic curve analysis, sST2 had a significantly good relationship with prognosis. On Kaplan-Meier curve and univariate Cox regression analyses, elevated sST2 and NT-proBNP level predicted poor outcome of the present patients with childhood IPAH/HPAH. Furthermore, patients with elevated sST2 had significantly worse prognosis among those with high NT-proBNP. Conclusions: The sST2 and NT-proBNP combination is a useful biomarker to predict clinical condition and outcome in patients with childhood IPAH/HPAH. (Circ J 2014; 78: 436–442)<br>
Journal
-
- Circulation Journal
-
Circulation Journal 78 (2), 436-442, 2014
The Japanese Circulation Society
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282680084650624
-
- NII Article ID
- 130003382228
-
- NII Book ID
- AA11591968
-
- COI
- 1:CAS:528:DC%2BC2cXltFKht7w%3D
-
- ISSN
- 13474820
- 13469843
-
- NDL BIB ID
- 025162696
-
- PubMed
- 24304538
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed